Goldman picks China healthcare stocks for a post-AI trade
Chinese corporate earnings are on a tear, giving investors clues on which stock sectors offer untapped returns, according…
China’s ‘landmark’ drug pricing guidelines widen biotech profit window: analysts
The State Council, China’s cabinet, has published guidelines on innovative drug pricing that a bank analyst has described…